tretazicar has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benouchan, M; Colombo, BM; Do Nascimento, F; Perret, GY | 1 |
1 other study(ies) available for tretazicar and B16 Melanoma
Article | Year |
---|---|
Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms.
Topics: Animals; Antineoplastic Agents; Aziridines; Bystander Effect; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Endothelium, Vascular; Escherichia coli; Genetic Therapy; Humans; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroreductases; Prodrugs; Transfection | 2006 |